市場は2023年から2028年に96億9,984万米ドル、予測期間中のCAGRは10.11％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、最近の免疫グロブリン製品の開発、免疫不全症や自己免疫疾患の有病率の上昇、高齢者人口の増加によって牽引されています。
本調査では、バイオテクノロジーと製造プロセスの進歩が、今後数年間の免疫グロブリン製品市場の成長を牽引する主要因の1つであると特定しています。また、皮下投与の採用が増加し、個別化医療への注目が高まっていることも、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global immunoglobulin products market 2018 - 2022
4.2 Product Segment Analysis 2018 - 2022
4.3 Route of Administration Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Product
6.1 Market segments
6.2 Comparison by Product
6.3 IgG - Market size and forecast 2023-2028
6.4 IgA - Market size and forecast 2023-2028
6.5 IgM - Market size and forecast 2023-2028
6.6 IgD - Market size and forecast 2023-2028
6.7 IgE - Market size and forecast 2023-2028
6.8 Market opportunity by Product
7 Market Segmentation by Route of Administration
7.1 Market segments
7.2 Comparison by Route of Administration
7.3 Intravenous (IV) - Market size and forecast 2023-2028
7.4 Subcutaneous (SC) - Market size and forecast 2023-2028
7.5 Intramuscular (IM) - Market size and forecast 2023-2028
7.6 Market opportunity by Route of Administration
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 UK - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 ADMA Biologics Inc.
12.4 Bio Products Laboratory Ltd.
12.5 Biocon Ltd.
12.6 CSL Ltd.
12.7 GC Biopharma corp.
12.8 Grifols SA
12.9 Kedrion S.p.A
12.10 LFB SA
12.11 Novartis AG
12.12 Octapharma AG
12.13 Pfizer Inc.
12.14 Serum Institute of India Pvt. Ltd.
12.15 Shanghai RAAS Blood Products Co. Ltd.
12.16 Taibang Biological Group Co. Ltd.
12.17 Taj Pharmaceuticals Ltd.
12.18 Takeda Pharmaceutical Co. Ltd.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global immunoglobulin products market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on IgG - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on IgG - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on IgG - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on IgG - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on IgA - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on IgA - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on IgA - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on IgA - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on IgM - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on IgM - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on IgM - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on IgM - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on IgD - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on IgD - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on IgD - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on IgD - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on IgE - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on IgE - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on IgE - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on IgE - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits57: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits69: Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
Exhibits70: Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Route of Administration ($ million)
Exhibits73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ million)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: ADMA Biologics Inc. - Overview
Exhibits124: ADMA Biologics Inc. - Business segments
Exhibits125: ADMA Biologics Inc. - Key offerings
Exhibits126: ADMA Biologics Inc. - Segment focus
Exhibits127: Bio Products Laboratory Ltd. - Overview
Exhibits128: Bio Products Laboratory Ltd. - Product / Service
Exhibits129: Bio Products Laboratory Ltd. - Key offerings
Exhibits130: Biocon Ltd. - Overview
Exhibits131: Biocon Ltd. - Business segments
Exhibits132: Biocon Ltd. - Key news
Exhibits133: Biocon Ltd. - Key offerings
Exhibits134: Biocon Ltd. - Segment focus
Exhibits135: CSL Ltd. - Overview
Exhibits136: CSL Ltd. - Business segments
Exhibits137: CSL Ltd. - Key news
Exhibits138: CSL Ltd. - Key offerings
Exhibits139: CSL Ltd. - Segment focus
Exhibits140: GC Biopharma corp. - Overview
Exhibits141: GC Biopharma corp. - Product / Service
Exhibits142: GC Biopharma corp. - Key offerings
Exhibits143: Grifols SA - Overview
Exhibits144: Grifols SA - Product / Service
Exhibits145: Grifols SA - Key offerings
Exhibits146: Kedrion S.p.A - Overview
Exhibits147: Kedrion S.p.A - Product / Service
Exhibits148: Kedrion S.p.A - Key offerings
Exhibits149: LFB SA - Overview
Exhibits150: LFB SA - Product / Service
Exhibits151: LFB SA - Key offerings
Exhibits152: Novartis AG - Overview
Exhibits153: Novartis AG - Business segments
Exhibits154: Novartis AG - Key news
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: Octapharma AG - Overview
Exhibits158: Octapharma AG - Product / Service
Exhibits159: Octapharma AG - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Serum Institute of India Pvt. Ltd. - Overview
Exhibits165: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits166: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits167: Shanghai RAAS Blood Products Co. Ltd. - Overview
Exhibits168: Shanghai RAAS Blood Products Co. Ltd. - Product / Service
Exhibits169: Shanghai RAAS Blood Products Co. Ltd. - Key offerings
Exhibits170: Taibang Biological Group Co. Ltd. - Overview
Exhibits171: Taibang Biological Group Co. Ltd. - Product / Service
Exhibits172: Taibang Biological Group Co. Ltd. - Key offerings
Exhibits173: Taj Pharmaceuticals Ltd. - Overview
Exhibits174: Taj Pharmaceuticals Ltd. - Product / Service
Exhibits175: Taj Pharmaceuticals Ltd. - Key offerings
Exhibits176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits178: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations
